• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新评估男性性别对甲状腺乳头状癌和微癌的预后意义:SEER 数据库分析。

Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis.

机构信息

Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People's Republic of China.

Department of Breast and Thyroid Surgery, Affiliated Nanshan Hospital, Guangdong Medical University, Shenzhen, China.

出版信息

Sci Rep. 2017 Sep 12;7(1):11412. doi: 10.1038/s41598-017-11788-8.

DOI:10.1038/s41598-017-11788-8
PMID:28900207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5595899/
Abstract

The prognostic significance of gender remains controversial for papillary thyroid carcinoma (PTC). In this study, we investigated the associations between gender and prognosis in a large cohort of patients with PTC or PTMC that was diagnosed in 2010-2013 and recorded in the Surveillance, Epidemiology, and End Results cancer registry. The mean ± standard deviation duration of survival for all patients with PTC during the study period was 21.47 ± 14.04 months. In Kaplan-Meier analyses of the entire cohort of PTC patients, survival curves for all-cause death and cancer-specific death declined more sharply for men than for women. Similar results were observed in analyses of patients with PTCs > 1 cm and PTMC. After adjusting for potential confounders, hazard rates indicated significantly elevated all-cause mortality for men in analyses of all PTCs, PTCs > 1 cm, and PTMCs. However, in a confounder-adjusted analysis of patients with PTMC, the hazard rate did not indicate significantly higher mortality for men than for women. Our study demonstrated that male gender is an independent poor prognostic factor for all PTCs and for PTCs > 1 cm. However, gender is not an independent prognostic factor for cause-specific survival in PTMC.

摘要

性别对甲状腺乳头状癌(PTC)的预后意义仍存在争议。本研究调查了 2010-2013 年间确诊于监测、流行病学和最终结果癌症登记处的大量 PTC 或微浸润性甲状腺癌(PTMC)患者中性别与预后的关系。在研究期间,所有 PTC 患者的平均生存时间±标准差为 21.47±14.04 个月。在整个 PTC 患者队列的 Kaplan-Meier 分析中,男性的全因死亡率和癌症特异性死亡率的生存曲线比女性下降得更陡峭。在分析 PTC >1cm 和 PTMC 的患者时,观察到了类似的结果。在校正潜在混杂因素后,在分析所有 PTC、PTC>1cm 和 PTMC 时,危险率表明男性的全因死亡率显著升高。然而,在对 PTMC 患者进行混杂因素校正分析时,危险率并未表明男性的死亡率显著高于女性。本研究表明,男性是所有 PTC 和 PTC>1cm 的独立不良预后因素。然而,在 PTMC 中,性别不是特定原因死亡率的独立预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c5/5595899/8ee608473d03/41598_2017_11788_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c5/5595899/4ae7ff93bcfb/41598_2017_11788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c5/5595899/b3fc7a8cebc2/41598_2017_11788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c5/5595899/8ee608473d03/41598_2017_11788_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c5/5595899/4ae7ff93bcfb/41598_2017_11788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c5/5595899/b3fc7a8cebc2/41598_2017_11788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c5/5595899/8ee608473d03/41598_2017_11788_Fig3_HTML.jpg

相似文献

1
Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis.重新评估男性性别对甲状腺乳头状癌和微癌的预后意义:SEER 数据库分析。
Sci Rep. 2017 Sep 12;7(1):11412. doi: 10.1038/s41598-017-11788-8.
2
Natural History and Prognostic Model of Untreated Papillary Thyroid Cancer: A SEER Database Analysis.未治疗的甲状腺乳头状癌的自然史和预后模型:SEER 数据库分析。
Cancer Control. 2024 Jan-Dec;31:10732748241253956. doi: 10.1177/10732748241253956.
3
Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.非手术治疗甲状腺乳头状癌的死亡率:主动监测的推论。
Thyroid. 2019 Oct;29(10):1409-1417. doi: 10.1089/thy.2019.0060. Epub 2019 Sep 24.
4
Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?年龄大于 60 岁预示着甲状腺乳头状癌患者预后较差:分期是否应该分为三个年龄组?
BMC Cancer. 2018 Mar 22;18(1):316. doi: 10.1186/s12885-018-4181-4.
5
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.甲状腺乳头状癌中肿瘤多灶性对临床结局的预后价值
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3241-3250. doi: 10.1210/jc.2017-00277.
6
Association of adjuvant radioactive iodine therapy with survival in node-positive papillary thyroid cancer.辅助放射性碘治疗与淋巴结阳性甲状腺乳头状癌患者生存的关系。
Oral Oncol. 2018 Dec;87:152-157. doi: 10.1016/j.oraloncology.2018.10.041. Epub 2018 Nov 8.
7
Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2,309 consecutive patients.甲状腺乳头状癌中肿瘤多灶性的预后意义及其与原发肿瘤大小的关系:对2309例连续患者的回顾性研究
Ann Surg Oncol. 2015 Jan;22(1):125-31. doi: 10.1245/s10434-014-3899-8. Epub 2014 Aug 5.
8
Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.预测甲状腺乳头状癌患者的生存情况:在两个当代国家患者队列中比较第七版和第八版美国癌症联合委员会/国际癌症控制联合会分期系统。
Thyroid. 2017 Nov;27(11):1408-1416. doi: 10.1089/thy.2017.0306. Epub 2017 Oct 5.
9
Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.比较双侧与单侧多灶性甲状腺乳头状癌的临床病理特征和预后:一项超过 2000 例连续患者的更新研究。
Cancer. 2016 Jan 15;122(2):198-206. doi: 10.1002/cncr.29689. Epub 2015 Oct 27.
10
Impact of Age on the Prognosis of Papillary Thyroid Carcinoma.年龄对甲状腺乳头状癌预后的影响
Arch Iran Med. 2020 Mar 1;23(3):169-174.

引用本文的文献

1
Sex disparities in papillary thyroid cancer survival: Divergent patterns of relative and absolute effects across the age spectrum.甲状腺乳头状癌生存中的性别差异:全年龄段相对效应和绝对效应的不同模式。
PLoS One. 2025 Jul 24;20(7):e0328876. doi: 10.1371/journal.pone.0328876. eCollection 2025.
2
Prognostic nomogram models for elderly patients with differentiated thyroid carcinoma: A population-based study.基于人群的研究:用于老年分化型甲状腺癌患者的预后列线图模型。
Medicine (Baltimore). 2024 Nov 1;103(44):e40381. doi: 10.1097/MD.0000000000040381.
3
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up.

本文引用的文献

1
Is Male Gender a Prognostic Factor for Papillary Thyroid Microcarcinoma?男性性别是甲状腺微小乳头状癌的一个预后因素吗?
Ann Surg Oncol. 2017 Jul;24(7):1958-1964. doi: 10.1245/s10434-017-5788-4. Epub 2017 Jan 27.
2
Upregulation of the ESR1 Gene and ESR Ratio (ESR1/ESR2) is Associated with a Worse Prognosis in Papillary Thyroid Carcinoma: The Impact of the Estrogen Receptor α/β Expression on Clinical Outcomes in Papillary Thyroid Carcinoma Patients.ESR1 基因和 ESR 比值(ESR1/ESR2)的上调与甲状腺乳头状癌预后不良相关:雌激素受体 α/β表达对甲状腺乳头状癌患者临床结局的影响。
Ann Surg Oncol. 2017 Nov;24(12):3754-3762. doi: 10.1245/s10434-017-5780-z. Epub 2017 Jan 25.
3
T1b-T2期甲状腺乳头状癌(PC)患者长期随访过程中进展的危险因素的作用
J Clin Med. 2024 Sep 11;13(18):5373. doi: 10.3390/jcm13185373.
4
Incidental thyroid carcinoma in an endemic goiter area in Italy: histopathological features and predictors of a common finding.意大利地方性甲状腺肿地区偶发甲状腺癌:常见发现的组织病理学特征和预测因素。
Endocrine. 2024 May;84(2):589-597. doi: 10.1007/s12020-023-03659-2. Epub 2024 Jan 13.
5
The usefulness and utilization of Gold-finger retractor for endoscopic thyroid surgery.金手指牵开器在甲状腺内镜手术中的应用和利用。
Front Endocrinol (Lausanne). 2023 Sep 19;14:1228657. doi: 10.3389/fendo.2023.1228657. eCollection 2023.
6
Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma.转录组分析揭示了根据甲状腺乳头状癌的亚型和性别失调的真菌组和古菌组以及独特的致癌特征。
Int J Mol Sci. 2023 Feb 5;24(4):3148. doi: 10.3390/ijms24043148.
7
Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma.甲状腺乳头状癌患者中非酒精性脂肪性肝病的患病率及其影响。
Endocrine. 2023 Jun;80(3):619-629. doi: 10.1007/s12020-023-03312-y. Epub 2023 Jan 25.
8
Incidental Papillary Microcarcinoma and Papillary Thyroid Carcinoma in Multinodular Goiter.多发性结节性甲状腺肿中的偶发甲状腺微小癌和甲状腺乳头状癌。
Anal Cell Pathol (Amst). 2023 Jan 14;2023:2768344. doi: 10.1155/2023/2768344. eCollection 2023.
9
Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis.分化型甲状腺癌肺转移患者的生存预后因素:一项系统评价和荟萃分析。
Front Oncol. 2022 Dec 15;12:990154. doi: 10.3389/fonc.2022.990154. eCollection 2022.
10
Preoperative prognostic risk stratification model for papillary thyroid carcinoma based on clinical and ultrasound characteristics.基于临床和超声特征的甲状腺乳头状癌术前预后风险分层模型。
Front Endocrinol (Lausanne). 2022 Oct 7;13:1025739. doi: 10.3389/fendo.2022.1025739. eCollection 2022.
Cancer Statistics, 2017.
《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
4
A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.甲状腺乳头状癌经典型与高细胞变异型的临床病理特征及预后比较:一项荟萃分析
Oncotarget. 2017 Jan 24;8(4):6222-6232. doi: 10.18632/oncotarget.14055.
5
Papillary thyroid microcarcinoma and active surveillance.甲状腺微小乳头状癌与主动监测
Lancet Diabetes Endocrinol. 2016 Dec;4(12):974-975. doi: 10.1016/S2213-8587(16)30269-8.
6
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?甲状腺微小乳头状癌:是否应该从手术转为主动监测?
Lancet Diabetes Endocrinol. 2016 Nov;4(11):933-942. doi: 10.1016/S2213-8587(16)30180-2. Epub 2016 Aug 20.
7
Recent incidences and differential trends of thyroid cancer in the USA.美国甲状腺癌的近期发病率及差异趋势。
Endocr Relat Cancer. 2016 Apr;23(4):313-22. doi: 10.1530/ERC-15-0445. Epub 2016 Feb 25.
8
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
9
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.主要甲状腺乳头状癌变体的临床病理差异风险与预后
J Clin Endocrinol Metab. 2016 Jan;101(1):264-74. doi: 10.1210/jc.2015-2917. Epub 2015 Nov 3.
10
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.